RecruitingNCT00588562
Rare Kidney Stone Consortium Patient Registry
Studying Adenine phosphoribosyltransferase deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- Dawn S. Milliner, M.D., M.DPrimary Hyperoxaluria Registry - Mayo Clinic, Rochester, MN
- Enrollment
- 730 enrolled
- Eligibility
- 0-100 years · All sexes
- Timeline
- 2003 – 2028
Study locations (4)
- Dent Disease Registry -Mayo Clinic, Rochester, Minnesota, United States
- Primary Hyperoxaluria Registry - Mayo Clinic, Rochester, Minnesota, United States
- Cystinuria Registry - New York University, New York, New York, United States
- APRT Registry - Landspitali Universtiy Hospital, Reykjavik, Iceland
Collaborators
National Institutes of Health (NIH) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Oxalosis and Hyperoxaluria Foundation (OHF)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00588562 on ClinicalTrials.govOther trials for Adenine phosphoribosyltransferase deficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT02026388Rare Kidney Stone Consortium BiobankMayo Clinic
- RECRUITINGNANCT06065852National Registry of Rare Kidney DiseasesUK Kidney Association
See all trials for Adenine phosphoribosyltransferase deficiency →